Insulet Corporation - Asset Resilience Ratio
Insulet Corporation (PODD) has an Asset Resilience Ratio of 3.71% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See PODD working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2005–2023)
This chart shows how Insulet Corporation's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Insulet Corporation assets under control.
Liquid Assets Composition Over Time
This chart breaks down Insulet Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Insulet Corporation (PODD) long-term investment share to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $128.70 Million | 3.71% |
| Total Liquid Assets | $128.70 Million | 3.71% |
Asset Resilience Insights
- Limited Liquidity: Insulet Corporation maintains only 3.71% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Insulet Corporation Industry Peers by Asset Resilience Ratio
Compare Insulet Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
DexCom Inc
NASDAQ:DXCM |
Medical Devices | 19.55% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
Annual Asset Resilience Ratio for Insulet Corporation (2005–2023)
The table below shows the annual Asset Resilience Ratio data for Insulet Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 2.07% | $53.50 Million | $2.59 Billion | -0.19pp |
| 2022-12-31 | 2.26% | $50.80 Million | $2.25 Billion | -- |
| 2021-12-31 | 0.00% | $0.00 | $2.05 Billion | -- |
| 2020-12-31 | 2.16% | $40.40 Million | $1.87 Billion | -12.05pp |
| 2019-12-31 | 14.21% | $162.40 Million | $1.14 Billion | -4.64pp |
| 2018-12-31 | 18.85% | $175.04 Million | $928.74 Million | -1.66pp |
| 2017-12-31 | 20.51% | $167.48 Million | $816.74 Million | -14.84pp |
| 2016-12-31 | 35.34% | $161.40 Million | $456.65 Million | -- |
| 2015-12-31 | 0.00% | $0.00 | $275.13 Million | -- |
| 2014-12-31 | 0.00% | $0.00 | $302.16 Million | -- |
| 2013-12-31 | 0.00% | $0.00 | $287.95 Million | -- |
| 2012-12-31 | 0.05% | $100.00K | $198.06 Million | -- |
| 2011-12-31 | 0.00% | $0.00 | $209.58 Million | -- |
| 2005-12-31 | 3.28% | $550.00K | $16.79 Million | -- |
About Insulet Corporation
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain… Read more